If you’ve been here for 4 years, I would absolutely LOVE to hear how your valuations are lower now than when the company was pre-revenue with no material contracts in place. Lower now than when the potential flows through the Spenda model are tens of billions. I’m all ears.
Yes, a lot higher than mid 20c imo. This is based purely on potential revenue data and obviously doesn’t take into consideration various market factors which could send the share price higher or lower than my modelling suggests.
My time frame to reach this target, ie when all current contracts (excluding eBev) are fully implemented and revenue flows have been maximised, is 2-3 years.
This is in no way financial advice, please don’t take it as so. My modelling has been wrong before.
- Forums
- ASX - By Stock
- Ann: Spenda partners with eBev to offer payments solutions
If you’ve been here for 4 years, I would absolutely LOVE to hear...
Featured News
Add SPX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $50.63M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $1.171K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 13239492 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 3266503 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 13239492 | 0.011 |
20 | 8223556 | 0.010 |
7 | 3629552 | 0.009 |
2 | 10062531 | 0.008 |
3 | 5232562 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 3266503 | 9 |
0.013 | 10368813 | 18 |
0.014 | 6820295 | 18 |
0.015 | 2137316 | 9 |
0.016 | 6251500 | 4 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online